Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046366
Filing Date
2025-03-28
Accepted
2025-03-28 10:46:50
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apto-20241231.htm   iXBRL 10-K 3358206
2 EX-19.1 apto-ex19_1.htm EX-19.1 556626
3 EX-21.1 apto-ex21_1.htm EX-21.1 5416
4 EX-23.1 apto-ex23_1.htm EX-23.1 11460
5 EX-31.1 apto-ex31_1.htm EX-31.1 14345
6 EX-31.2 apto-ex31_2.htm EX-31.2 14339
7 EX-32.1 apto-ex32_1.htm EX-32.1 6779
8 EX-32.2 apto-ex32_2.htm EX-32.2 6891
9 EX-97.1 apto-ex97_1.htm EX-97.1 51333
10 GRAPHIC img210773660_0.jpg GRAPHIC 4269
11 GRAPHIC img239754434_0.jpg GRAPHIC 208154
12 GRAPHIC img239754434_1.jpg GRAPHIC 8556
13 GRAPHIC img239754434_2.jpg GRAPHIC 4269
  Complete submission text file 0000950170-25-046366.txt   13581173

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apto-20241231.xsd EX-101.SCH 1690717
99 EXTRACTED XBRL INSTANCE DOCUMENT apto-20241231_htm.xml XML 2061810
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32001 | Film No.: 25781886
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)